.
MergerLinks Header Logo

New Deal


Announced

Azimut Libera Impresa to acquire a 30% stake in The Longevity Suite.

Financials

Edit Data
Transaction Value-
Consideration TypeCash
Capital Owned-
Capital Bid For30%
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Sources

Edit

Tags

Edit

Acquisition

Single Bidder

Domestic

Private

health advice

Minority

Pending

Italy

Health Care Services

biohacking

Private Equity

Friendly

Synopsis

Edit

Azimut Libera Impresa, an Italian asset management company, agreed to acquire a 30% stake in The Longevity Suite, a biohacking & anti-aging company. Financial terms were not disclosed. "Today is another important milestone for Longevity, which thanks to this operation will be able to continue pursuing its vision by offering a unique wellness experience to an ever-increasing number of clients. We are very satisfied as we are certain that we have found an institutional shareholder who, sharing the aspirations and values ​​of our company, will be able to support our growth project," Luigi Caterino, Longevity Founder and CEO.

Search a database of more than 250,000 verified dealmakers

Receive automated updates on global transactions

Follow the activity, relationships and transactions of top dealmakers

No credit card required

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US